755 results
Responsible body
CHMP Remove CHMP filter
-
List item
News: EMA issues advice on use of antibody combination (bamlanivimab / etesevimab)
CHMP, Last updated: 05/03/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-29 January 2021 (updated)
Virtual meeting, from 25/01/2021 to 29/01/2021, Last updated: 04/03/2021 -
List item
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 11 March 2021
Virtual meeting, 11/03/2020, Last updated: 02/03/2021 -
List item
News: First oral treatment for spinal muscular atrophy (SMA) recommended for approval
CHMP, Last updated: 26/02/2021 -
List item
News: EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab)
CHMP, Last updated: 26/02/2021 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021
CHMP, Last updated: 26/02/2021 -
List item
News: Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers
CHMP, Last updated: 25/02/2021 -
List item
News: EMA starts evaluating use of Veklury in COVID-19 patients not requiring supplemental oxygen
CHMP, Last updated: 23/02/2021 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-29 January 2021
CHMP, Last updated: 01/02/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-28 May 2020
European Medicines Agency, Amsterdam, the Netherlands, from 25/05/2020 to 28/05/2020, Last updated: 27/01/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 November 2020
Virtual meeting, from 09/11/2020 to 12/11/2020, Last updated: 07/01/2021 -
List item
News: EMA recommends first COVID-19 vaccine for authorisation in the EU
CHMP, Last updated: 22/12/2020 -
List item
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 12 January 2021
Virtual meeting, 12/01/2021, Last updated: 17/12/2020 -
List item
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 6 January 2021
Virtual meeting, 06/01/2021, Last updated: 17/12/2020 -
List item
News: Update on assessment of marketing authorisation application for Moderna’s mRNA-1273 COVID-19 vaccine
CHMP, Last updated: 17/12/2020 -
List item
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 29 December 2020
Virtual meeting, 29/12/2020, Last updated: 15/12/2020 -
List item
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 21 December 2020
Virtual meeting, 21/12/2020, Last updated: 15/12/2020 -
List item
News: Update on assessment of the BioNTech and Pfizer BNT162b2 vaccine marketing authorisation application
CHMP, Last updated: 15/12/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 December 2020
CHMP, Last updated: 11/12/2020 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2020
CHMP, Last updated: 13/11/2020 -
List item
News: Ulipristal acetate for uterine fibroids: EMA recommends restricting use
CHMP, Last updated: 13/11/2020 -
List item
News: Nitrosamines: EMA aligns recommendations for sartans with those for other medicines
CHMP, Last updated: 13/11/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 July 2020
Virtual meeting, from 20/07/2020 to 23/07/2020, Last updated: 29/10/2020 -
List item
News: First long-acting injectable antiretroviral therapy for HIV recommended for approval
CHMP, Last updated: 16/10/2020 -
List item
News: First treatment for rare condition primary hyperoxaluria type 1
CHMP, Last updated: 16/10/2020